We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NEM:ASXNewmont Corporation Registered Shs Chess Depositary Interests Repr 1 Sh Analysis

Data as of 2026-08-21 - not real-time

A$179.10

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Newmont Corporation trades at AUD 179.10, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has gained 31.8%. RSI sits at 77.5, which reads as overbought, and MACD momentum is bullish. The recent range runs from support at AUD 130.16 up to resistance at AUD 179.89.
The shares look fair at 16.0 times earnings, though no sector average was available for comparison. Revenue is growing at 15.1% on a 33.4% profit margin. The 0.84% dividend yield looks covered by current payout levels.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 38.9%, a beta of 0.89 and a maximum drawdown of 31.8%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 4/10 conviction on the long call.

Top Market Events

- 19 August 2026 - - News WRITTEN BY France Pinzon StrikePoint Gold TSX-V:SKP has agreed to acquire the Northumberland...Newmont Corp NEM reports a robust second quarter with record free cash flow and strategic project progress, despite...What’s happening with Core Lithium Ltd ASX: CXO , Newmont Corporation ASX: NEM , and Life360 Inc ASX: 360 shares?

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • RSI at 77.5 signals overbought conditions
  • Trading above the 200-day average of 152.70
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • RSI at 77.5 signals overbought conditions
  • Trading above the 200-day average of 152.70
  • MACD momentum is positive

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Profit margin of 33.4% is healthy
  • Revenue growth of +15.1%
  • P/E ratio of 16.0

Key Metrics & Analysis

Financial Health

Revenue Growth15.10%
Profit Margin33.36%
P/E Ratio16.0
ROE25.91%
ROA15.75%
Debt/Equity15.81
P/B Ratio3.8
Op. Cash FlowA$12.6B
Free Cash FlowA$8.8B

Technical Analysis

TrendNeutral
RSI77.5
SupportA$130.16
ResistanceA$179.89
MA 20A$152.84
MA 50A$144.08
MA 200A$152.70
MACDBullish
VolumeIncreasing
Fear & Greed Index92.84

Valuation

Fair ValueA$204.60
Target PriceA$182.61
Upside/Downside1.96%
GradeFair
TypeGrowth
Dividend Yield0.84%

Risk Assessment

Beta0.89
Volatility38.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.